Industry Alliance Program
CIRM established the Industry Alliance Program (IAP) as a direct opportunity for the industry to partner with CIRM in accelerating the most promising stem cell, gene, and regenerative medicine therapy programs to commercialization. Under the umbrella of the IAP is the Industry Resource Partner Program (IRP) that provides valuable resources that help CIRM-funded projects advance through various stages of development—including discovery, translational, and clinical, towards commercialization.
$25+ billion
in follow on funding
1,400+
Projects funded
50+
Companies with roots in CIRM-funded projects
Contact the CIRM
Preclinical Development team to learn more.
Industry Resource Partner Program (IRP)
CIRM’s Industry Resource Partner Program (IRP) connects industry resources to our awardees to help them advance their research at various stags through to commercialization. Below is our current list partners and their capabilities and offerings. If you would like to learn more about our partners, please email us at preclinical@cirm.ca.gov.
